POSIMIR ® (bupivacaine solution) for infiltration use reduced mean pain over 72 hours after arthroscopic subacromial decompression surgery compared with vehicle control and improved several measures ...

CUPERTINO, Calif., Feb. 2, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that the U.S. Food and Drug Administration (FDA) has approved POSIMIR® (bupivacaine solution) for ...

Please provide your email address to receive an email when new articles are posted on . Subacromial decompression with arthroscopic rotator cuff repair yielded a 21% risk reduction for revision ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Published results showed patients with shoulder ...

Posimir is a novel formulation of bupivacaine, an amide local anesthetic, designed to be administered directly into the surgical site. Posimir ® (bupivacaine solution) is now available for ...

POSIMIR® is now commercially available in the U.S. for the treatment of post-surgical pain in adults following arthroscopic subacromial decompression surgery DURECT recently received an $8 million ...

Arthroscopic subacromial decompression surgery does not reduce pain any more than arthroscopy alone in people with shoulder impingement, researchers say. "[T]he findings from our study suggest that ...

Tim Jones receives funding from the National Institute for Health Research (NIHR), Department of Health and Social Care, UK. The views expressed in this article are those of the author(s) and not ...